Statera Biopharma, Inc. Increase (Decrease) in Restricted Cash
Statera Biopharma, Inc. reported Increase (Decrease) in Restricted Cash of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-06.
Discontinued › Notes
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-03-06
- Statera Biopharma, Inc. increase (decrease) in restricted cash for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Statera Biopharma, Inc. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $250.00.
- Statera Biopharma, Inc. increase (decrease) in restricted cash for the quarter ending 2015-12-31 was -$20.35K.
- Statera Biopharma, Inc. increase (decrease) in restricted cash for the quarter ending 2013-12-31 was $75.88K.
- Statera Biopharma, Inc. increase (decrease) in restricted cash for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Statera Biopharma, Inc. increase (decrease) in restricted cash for fiscal 2016 was $2.58K.
- Statera Biopharma, Inc. increase (decrease) in restricted cash for fiscal 2015 was -$407.10K.
- Statera Biopharma, Inc. increase (decrease) in restricted cash for fiscal 2013 was $1.50M, a 2.83% decline from fiscal 2012.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $0.00 10-K · filed 2018-03-06 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | ||
| 2016-12-31 | $250.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $2.58K 10-K · filed 2018-03-06 | |
| 2016-09-30 | $2.33K 10-Q · filed 2017-11-14 | ||
| 2015-12-31 | -$20.35K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | -$407.10K 10-K · filed 2017-02-22 | |
| 2015-09-30 | -$386.75K 10-Q · filed 2016-11-14 | ||
| 2013-12-31 | $75.88K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $1.50M 10-K · filed 2014-03-17 | |
| 2013-09-30 | $1.42M 10-Q · filed 2013-11-08 | ||
| 2012-12-31 | $1.54M 10-K · filed 2014-03-17 |